Comments

Kyverna Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Kyverna Therapeutics (KYTX) operate in?

Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

KYTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.38

0.114.85%

At close: -

$2.38

0.000.00%

After Hours: Mar 21, 4:02 PM EDT

Kyverna Therapeutics (KYTX) Forecast

News Earnings Kyverna Therapeutics (KYTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Kyverna Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:KYTX | Benzinga

Explore Kyverna Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KYTX.

Open	$2.24
Close	$2.38
Volume / Avg.	470.93K / 356.89K
Day Range	$2.20 - $2.46
52 Wk Range	2.25 - 28.05
Market Cap	$102.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	9.2%
Days to Cover	11.43

Recent News

Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Home Depot, Paysafe And 3 Stocks To Watch Heading Into Tuesday

Avi Kapoor

Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges

CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's remarkable remission. This breakthrough offers new hope for autoimmune disease patients but faces challenges in cost and manufacturing.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.24
Close	$2.38
Volume / Avg.	470.93K / 356.89K
Day Range	$2.20 - $2.46
52 Wk Range	2.25 - 28.05
Market Cap	$102.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	9.2%
Days to Cover	11.43

About Kyverna Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kyverna Therapeutics (KYTX) stock?

You can purchase shares of Kyverna Therapeutics (NASDAQ:KYTX) through any online brokerage.

View our list of the best stock brokerages

Who are Kyverna Therapeutics (KYTX) competitors?

Other companies in Kyverna Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), OncoCyte (NASDAQ:OCX) and Atossa Therapeutics (NASDAQ:ATOS).

What is the forecast, or price target, for Kyverna Therapeutics (KYTX) stock?

Kyverna Therapeutics has a consensus price target of $23.20.

What is the current price for Kyverna Therapeutics (KYTX)?

The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $2.38 last updated March 21, 2025 at 4:02 PM EDT.

Does Kyverna Therapeutics (KYTX) pay a dividend?

There are no upcoming dividends for Kyverna Therapeutics.

When is Kyverna Therapeutics (NASDAQ:KYTX) reporting earnings?

Kyverna Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Kyverna Therapeutics (KYTX) going to split?

There is no upcoming split for Kyverna Therapeutics.

What sector and industry does Kyverna Therapeutics (KYTX) operate in?

Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.